Perfluoro-n-[1,2-13C2] decanoic acid (MPFDA)

Forever chemicals turn up in drinking water, food packaging, and everyday household products, and once they get into your body they can linger for years. This test looks in your urine for one specific member of that family, giving you a window into an exposure that no routine checkup measures.

This is an early-stage research marker, not a settled clinical test. It can hint at whether your body is carrying this compound, but there are no agreed-upon normal numbers yet, and a single reading is best treated as one data point rather than a verdict.

What This Chemical Actually Is

The compound measured here is PFDA (perfluorodecanoic acid), a long-chain member of a large group of industrial chemicals called PFAS (per- and polyfluoroalkyl substances, widely known as forever chemicals). Their nickname comes from an extremely stable chemical structure that resists breakdown, both in the environment and inside your body.

Because they break down so slowly, long-chain PFAS like this one can stay in a person for years after exposure. On a lab report the result may appear under a technical label tied to the mass-labeled standard used to measure it, but what is being quantified is perfluorodecanoic acid in your urine.

Why Urine Is a Tricky Window

Urine reflects what your kidneys are filtering and eliminating, not the total amount stored in your body. Long-chain PFAS spend most of their time in the blood, bound to proteins, and only a fraction leaves through urine at any given moment. In the general population, these long-chain compounds are frequently below the limit of detection in urine, which is why urine is not a dependable matrix for everyday exposure monitoring.

In the one human dosing experiment available, elimination of long-chain perfluorocarboxylic acids was only partly explained by urine, with some also leaving through the stool. So a urinary level captures a slice of ongoing elimination rather than a clean read on your full body burden.

What Higher Levels May Signal

The most plausible meaning of a higher urine level is greater exposure and more active handling of the chemical by your kidneys. In workers with heavy occupational exposure, urinary PFAS lined up closely with blood PFAS, with a strong statistical link (correlation coefficients of 0.57 to 0.93, where 1.0 would be a perfect match). That tight correlation was seen only in these very heavily exposed workers, not in the general population, where urinary levels are usually undetectable.

A lower or undetectable result is harder to interpret. It could mean lower exposure, but the available evidence does not establish whether it also reflects better retention, slower excretion, or a healthier state, so it should not be read as an all-clear.

Kidney Function

These chemicals tend to collect in the kidney, which is why that organ draws the most attention. In a study of 225 adults, higher PFAS exposure tracked with higher uric acid and creatinine and a lower kidney filtration rate (a rough measure of how well the kidneys clean the blood), and urinary PFAS lined up with small-molecule markers of kidney stress.

Some blood-based studies point the other way. In roughly 1,000 older adults followed from age 70 to 80, and in a 10-year study of younger people, blood PFDA was linked to higher, not lower, filtration rates.

This is not a clean good-number, bad-number marker. Your kidney filtration rate itself partly determines how much of the chemical stays in your blood versus leaves in urine, so the relationship can run in both directions depending on who is studied and which fluid is measured. Read this result as an exposure and kidney-handling signal, not as proof that the chemical is helping or harming your kidneys.

Pregnancy and Birth Outcomes

The pregnancy evidence comes from PFDA measured in blood, not urine, so it is context rather than direct evidence about this test. In a group of 501 pregnancies, women in the higher range of early-pregnancy blood PFDA had about 60% higher odds of one type of preterm birth (odds ratio 1.60, just reaching statistical significance). A pooled analysis of 46 studies linked higher PFDA to modestly lower birth weight (about 24 grams lower) and a greater chance of a smaller-than-expected newborn.

A large pregnancy study of 2,343 women found no clear overall link between blood PFDA and preeclampsia (a serious blood-pressure complication), but in certain subgroups the odds were more than doubled. Whether urinary PFDA carries any of these same associations has not been tested.

Other Conditions Tied to Blood PFDA

In a study of 1,878 adults, each step up in blood PFDA was tied to about 12% higher odds of developing painful hand osteoarthritis, though the pattern was not consistent across exposure groups. In a separate 10-year study of 1,158 women, higher blood PFDA was linked to roughly 26% lower risk of developing uterine fibroids, an inverse relationship that ran opposite to expectations.

Cancer links are not established. A case study of 800 women found no clear connection between blood PFDA and thyroid cancer, and a pooled analysis of common cancers likewise found no significant association. As with the pregnancy data, all of this rests on blood measurements, and none of it has been confirmed for urinary levels.

Why One Reading Is Not Enough

Because this chemical leaves the body slowly, your level reflects a long, integrated history of exposure rather than what you ate last week. Biological half-lives across this chemical family, meaning how long they persist in the body overall rather than just in urine, have been estimated at anywhere from under a year for the shortest compounds to several years for the more persistent ones, so meaningful change usually plays out over months to years, not days.

That slow timeline is exactly why a single number is limited and a trend is more useful. Get a baseline, and if you take steps to reduce exposure, retest in 6 to 12 months to see whether the direction is moving. Keep in mind that urine is not the most reliable matrix for these long-chain compounds, so pairing repeat testing with a blood PFAS panel gives a steadier picture.

What to Do With an Unexpected Result

If the chemical is detectable or high, the first move is confirmation, because urine is an incomplete window into body burden. A serum (blood) PFAS panel is the more established way to gauge how much you are actually carrying, and it can settle whether a surprising urine value is real.

From there, the pathway is to hunt for the source and check the organ most affected. Investigate your drinking water and any occupational or firefighting-foam exposure, and order kidney markers such as filtration rate, cystatin C, uric acid, and urine albumin. If those kidney numbers are drifting, an environmental health specialist or a nephrologist is the right person to bring in.

When Results Can Be Misleading

• Undetectable does not mean absent: for long-chain PFAS, urine levels are often below the detection limit even when blood carries a meaningful amount, so a low or negative urine result can miss real body burden.
• Hydration and urine concentration: how dilute your urine is can shift the raw number, which is why results are usually adjusted for urine creatinine. A very dilute or very concentrated sample can distort a single reading.
• Kidney function changes clearance: how fast your kidneys filter blood affects how much of the chemical appears in urine, so a shifting filtration rate can move the result without any change in your actual exposure.
• It reflects elimination, not the whole store: a urine value captures what is leaving the body, not the total amount held in blood and tissue, so it should be read alongside a blood measurement rather than on its own.